Humanwell Healthcare Group Stock Current Valuation
| 600079 Stock | 19.82 0.07 0.35% |
Valuation analysis of Humanwell Healthcare helps investors to measure Humanwell Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Humanwell Healthcare's Cash is projected to increase significantly based on the last few years of reporting. The current year's Total Cash From Operating Activities is expected to grow to about 2.4 B, whereas Other Cashflows From Financing Activities is projected to grow to (118.1 M). Fundamental drivers impacting Humanwell Healthcare's valuation include:
Price Book 1.8105 | Enterprise Value 37.1 B | Enterprise Value Ebitda 10.2408 | Price Sales 1.2633 | Trailing PE 16.6219 |
Overvalued
Today
Please note that Humanwell Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Humanwell Healthcare is based on 3 months time horizon. Increasing Humanwell Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Humanwell Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Humanwell Stock. However, Humanwell Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.82 | Real 18.79 | Hype 20.06 |
The real value of Humanwell Stock, also known as its intrinsic value, is the underlying worth of Humanwell Healthcare Company, which is reflected in its stock price. It is based on Humanwell Healthcare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Humanwell Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Humanwell Healthcare Group helps investors to forecast how Humanwell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Humanwell Healthcare more accurately as focusing exclusively on Humanwell Healthcare's fundamentals will not take into account other important factors: Humanwell Healthcare Group Company Current Valuation Analysis
Humanwell Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Humanwell Healthcare Current Valuation | 37.09 B |
Most of Humanwell Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Humanwell Healthcare Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Humanwell Healthcare Group has a Current Valuation of 37.09 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is notably lower than that of the firm.
Humanwell Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Humanwell Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Humanwell Healthcare could also be used in its relative valuation, which is a method of valuing Humanwell Healthcare by comparing valuation metrics of similar companies.Humanwell Healthcare is currently under evaluation in current valuation category among its peers.
Humanwell Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0601 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 37.09 B | ||||
| Shares Outstanding | 1.63 B | ||||
| Shares Owned By Insiders | 36.45 % | ||||
| Shares Owned By Institutions | 21.40 % | ||||
| Price To Book | 1.81 X | ||||
| Price To Sales | 1.26 X | ||||
| Revenue | 24.52 B | ||||
| Gross Profit | 11.87 B | ||||
| EBITDA | 4.23 B | ||||
| Net Income | 2.13 B | ||||
| Total Debt | 6.71 B | ||||
| Book Value Per Share | 11.18 X | ||||
| Cash Flow From Operations | 1.97 B | ||||
| Earnings Per Share | 1.19 X | ||||
| Target Price | 24.75 | ||||
| Number Of Employees | 17.68 K | ||||
| Beta | 0.84 | ||||
| Market Capitalization | 32.29 B | ||||
| Total Asset | 36.2 B | ||||
| Retained Earnings | 9.36 B | ||||
| Working Capital | 6.41 B | ||||
| Net Asset | 36.2 B | ||||
| Last Dividend Paid | 0.46 |
About Humanwell Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Humanwell Healthcare Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humanwell Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humanwell Healthcare Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Humanwell Stock
Humanwell Healthcare financial ratios help investors to determine whether Humanwell Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humanwell with respect to the benefits of owning Humanwell Healthcare security.